Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn's disease strictures

Journal of Crohn's and Colitis

Volumn 8, Issue 5, 2014, Pages 392-400

  Atreja, Ashish ^a   Aggarwal, Ashish ^b   Dwivedi, Saurabh ^b   Rieder, Florian ^b   Lopez, Rocio ^b   Lashner, Bret A ^b   Brzezinski, Aaron ^b   Vargo, John J ^b   Shen, Bo ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Crohn's disease; Endoscopic dilation; Outcomes; Strictures

Indexed keywords

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CROHN DISEASE; DILATATION; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; TREATMENT OUTCOME; COHORT ANALYSIS; COLONOSCOPY; COMPARATIVE STUDY; COMPLICATION; CONSTRICTION, PATHOLOGIC; DEVICES; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; REOPERATION; REPRODUCIBILITY;

ADULT; COHORT STUDIES; COLONOSCOPY; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; DILATATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; REOPERATION; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 84897439837     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.10.001     Document Type: Article

References (26)

1. Lichtenstein G.R., Hanauer S.B., Sandborn W.J. Management of Crohn's disease in adults. Am J Gastroenterol 2009, 104:465-483. [quiz 464, 484].
2. Rieder F., Fiocchi C. Intestinal fibrosis in IBD-a dynamic, multifactorial process. Nat Rev Gastroenterol Hepatol 2009, 6:228-235.
3. Cosnes J., Cattan S., Blain A., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002, 8:244-250.
4. Lichtenstein G.R., Olson A., Travers S., et al. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease. Am J Gastroenterol 2006, 101:1030-1038.
5. Abreu M.T., Taylor K.D., Lin Y.C., et al. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology 2002, 123:679-688.
6. Wibmer A.G., Kroesen A.J., Grone J., et al. Comparison of strictureplasty and endoscopic balloon dilatation for stricturing Crohn's disease-review of the literature. Int J Colorectal Dis 2010, 25:1149-1157.
7. Yamamoto T. Factors affecting recurrence after surgery for Crohn's disease. World J Gastroenterol 2005, 11:3971-3979. [14].
8. Koltun W.A. Long-term value of endoscopic dilatation for Crohn's strictures. Gut 2010, 59:288.
9. Shen B., Fazio V.W., Remzi F.H., et al. Endoscopic balloon dilation of ileal pouch strictures. Am J Gastroenterol 2004, 99:2340-2347.
10. Shen B., Lian L., Kiran R.P., et al. Efficacy and safety of endoscopic treatment of ileal pouch strictures. Inflamm Bowel Dis 2011, 23.
11. Van Assche G., Vermeire S., Rutgeerts P. Endoscopic therapy of strictures in Crohn's disease. Inflamm Bowel Dis 2007, 13:356-358.
12. Mueller T., Rieder B., Bechtner G., et al. The response of Crohn's strictures to endoscopic balloon dilation. Aliment Pharmacol Ther 2010, 31:634-639.
13. Hoffmann J.C., Heller F., Faiss S., et al. Through the endoscope balloon dilation of ileocolonic strictures: prognostic factors, complications, and effectiveness. Int J Colorectal Dis 2008, 23:689-696.
14. Hassan C., Zullo A., De Francesco V., et al. Systematic review: endoscopic dilatation in Crohn's disease. Aliment Pharmacol Ther 2007, 26:1457-1464.
15. D'Haens G., Van Deventer S., Van Hogezand R., et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial. Gastroenterology 1999, 116:1029-1034.
16. Sorrentino D. Role of biologics and other therapies in stricturing Crohn's disease: what have we learnt so far?. Digestion 2008, 77:38-47.
17. East J.E., Brooker J.C., Rutter M.D., et al. A pilot study of intrastricture steroid versus placebo injection after balloon dilatation of Crohn's strictures. Clin Gastroenterol Hepatol 2007, 5:1065-1069.
18. Brooker J.C., Beckett C.G., Saunders B.P., et al. Long-acting steroid injection after endoscopic dilation of anastomotic Crohn's strictures may improve the outcome: a retrospective case series. Endoscopy 2003, 35:333-337.
19. Brower R.A. Hydrostatic balloon dilation of a terminal ileal stricture secondary to Crohn's disease. Gastrointest Endosc 1986, 32:38-40.
20. Van Assche G., Thienpont C., D'Hoore A., et al. Long-term outcome of endoscopic dilatation in patients with Crohn's disease is not affected by disease activity or medical therapy. Gut 2010, 59:320-324.
21. Gustavsson A., Magnuson A., Blomberg B., et al. Endoscopic dilation is an efficacious and safe treatment of intestinal strictures in Crohn's disease. Aliment Pharmacol Ther 2012, 36:151-158.
22. Vrabie R., Irwin G.L., Friedel D. Endoscopic management of inflammatory bowel disease strictures. World J Gastrointest Endosc 2012, 4:500-505.
23. Shah P., Ahmad N.A. Endoscopic balloon dilation: the panacea for Crohn's strictures?. Gastroenterology 2011, 140:721-723.
24. Scimeca D., Mocciaro F., Cottone M., et al. Efficacy and safety of endoscopic balloon dilation of symptomatic intestinal Crohn's disease strictures. Dig Liver Dis 2011, 43:121-125.
25. Popov Y., Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology 2009, 50:1294-1306.
26. Szabo H., Fiorino G., Spinelli A., et al. Review article: anti-fibrotic agents for the treatment of Crohn's disease-lessons learnt from other diseases. Aliment Pharmacol Ther 2010, 31:189-201.